Evidence map›Paper›PMID 24050720›Full record

ArticleBiological psychiatry2014

Automatic auditory processing deficits in schizophrenia and clinical high-risk patients: forecasting psychosis risk with mismatch negativity.

Veronica B Perez, Scott W Woods, Brian J Roach, Judith M Ford, Thomas H McGlashan, Vinod H Srihari, Daniel H Mathalon

2 registry-linked trialsAbstract read
In one paragraph

Article in Biological psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 122 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
122citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02069925 nacompletednot on this map

STEP-ED: Reducing Duration of Untreated Psychosis and Its Impact in the U.S.

TypeinterventionalSponsorYale UniversityRan2014 to 2020Enrolled285ConditionsPsychosis, SchizophreniaArmsEarly Detection (ED), Usual Detection
NCT05142735 narecruitingnot on this mapstarted 2023, after this paper: background citation

Effects of N-acetylcysteine on Psychosis-like Symptoms and a Neurophysiological Biomarker of the Clinical High Risk for Schizophrenia

TypeinterventionalSponsorCentre for Addiction and Mental HealthRan2023 to 2026Enrolled90ConditionsProdromal SchizophreniaArmsN-Acetylcysteine, Placebo
3 · Its place in the literature

Who cites it

122 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Reliability of mismatch negativity event-related potentials in a multisite, traveling subjects study.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2020
    Trial
  11. Trial
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Neighborhood social fragmentation in relation to impaired mismatch negativity among youth at clinical high risk for psychosis and healthy comparisons.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  19. Article
  20. Article

62 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Veronica B PerezUniversity of California, San Francisco, California; San Francisco Veterans Administration Medical Center, San Francisco, California.
Scott W WoodsYale University School of Medicine, New Haven, Connecticut.
Brian J RoachUniversity of California, San Francisco, California; San Francisco Veterans Administration Medical Center, San Francisco, California.
Judith M FordUniversity of California, San Francisco, California; San Francisco Veterans Administration Medical Center, San Francisco, California.
Thomas H McGlashanYale University School of Medicine, New Haven, Connecticut.
Vinod H SrihariYale University School of Medicine, New Haven, Connecticut.
Daniel H MathalonUniversity of California, San Francisco, California; San Francisco Veterans Administration Medical Center, San Francisco, California. Electronic address: daniel.mathalon@ucsf.edu.

Funding

Predictive Coding Abnormalities in Psychosis: EEG and fMRIR01MH058262 · NIMH · YALE UNIVERSITY · PI FORD, JUDITH M · 1998 to 2018
$6.4M
8/9 Predictors and Mechanisms of Conversion to PsychosisU01MH082022 · NIMH · YALE UNIVERSITY · PI WOODS, SCOTT W · 2008 to 2018
$6.0M
STEP-ED:Reducing Duration of Untreated Psychosis and its Impact in the U.S.R01MH103831 · NIMH · YALE UNIVERSITY · PI SRIHARI, VINOD H. · 2013 to 2017
$3.9M
Functional Brain Abnormalities in the Schizophrenia ProdromeR01MH076989 · NIMH · YALE UNIVERSITY · PI MATHALON, DANIEL H · 2007 to 2014
$2.3M
Neurobiological Mechanisms Underlying the Symptoms and Course of SchizophreniaT32MH089920 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FORD, JUDITH M · 2010 to 2014
$1.3M
Neurobiology of response monitoring failure in schizophreniaK02MH067967 · NIMH · YALE UNIVERSITY · PI FORD, JUDITH M · 2003 to 2010
$1.1M
NIMH NIH HHS K02 MH067967NIMH NIH HHS R01 MH058262NIMH NIH HHS R01 MH076989NIMH NIH HHS R01 MH103831NIMH NIH HHS T32 MH089920NIMH NIH HHS U01 MH082022
6 · The paper itself

Abstract

backgroundOnly about one third of patients at high risk for psychosis based on current clinical criteria convert to a psychotic disorder within a 2.5-year follow-up period. Targeting clinical high-risk (CHR) individuals for preventive interventions could expose many to unnecessary treatments, underscoring the need to enhance predictive accuracy with nonclinical measures. Candidate measures include event-related potential components with established sensitivity to schizophrenia. Here, we examined the mismatch negativity (MMN) component of the event-related potential elicited automatically by auditory deviance in CHR and early illness schizophrenia (ESZ) patients. We also examined whether MMN predicted subsequent conversion to psychosis in CHR patients.

methodsMismatch negativity to auditory deviants (duration, frequency, and duration + frequency double deviant) was assessed in 44 healthy control subjects, 19 ESZ, and 38 CHR patients. Within CHR patients, 15 converters to psychosis were compared with 16 nonconverters with at least 12 months of clinical follow-up. Hierarchical Cox regression examined the ability of MMN to predict time to psychosis onset in CHR patients.

resultsIrrespective of deviant type, MMN was significantly reduced in ESZ and CHR patients relative to healthy control subjects and in CHR converters relative to nonconverters. Mismatch negativity did not significantly differentiate ESZ and CHR patients. The duration + frequency double deviant MMN, but not the single deviant MMNs, significantly predicted the time to psychosis onset in CHR patients.

conclusionsNeurophysiological mechanisms underlying automatic processing of auditory deviance, as reflected by the duration + frequency double deviant MMN, are compromised before psychosis onset and can enhance the prediction of psychosis risk among CHR patients.

Indexed as

Predictive Value of TestsAdolescentCase-Control StudiesDisease ProgressionEvoked Potentials, AuditoryFemaleHumansMalePsychiatric Status Rating ScalesPsychotic DisordersRiskSchizophreniaYoung AdultAuditory cortexclinical high-risk for psychosisevent-related potentiallongitudinalmismatch negativitypsychosisschizophrenia

Identifiers

PMID24050720
PMCPMC4028131

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.